Amplyx Pharmaceuticals, Inc

Amplyx Pharmaceuticals, Inc

Amplyx Pharmaceuticals, Inc

Amplyx Pharmaceuticals is developing novel, broadspectrum antifungal agents for the treatment of lifethreatening invasive fungal infections due to candida, aspergillus and rare molds..
Type
B2b
Raised
$75.7M
Follow us
Alexa global traffic share
Latest funding
$67,000,000
Venture capital (Series C) - 2017
3x5 Special Opportunity Fund NEA BioMed Ventures +5
$8,700,000
Venture capital (Series B) - 2016
3×5 Partners
Team Size
2
Employees
$8,700,000 Venture capital (Series B)
FinSMEs

Amplyx Pharmaceuticals Raises $8.7M Investment from 3×5 Partners

Health Funding